A new kind of antipsychotic: what the Cobenfy trial found
Since the 1950s, every antipsychotic has blocked dopamine receptors. Cobenfy takes a different route.
How treatments for schizophrenia work, what the evidence shows, and the new medicines in trials.
Since the 1950s, every antipsychotic has blocked dopamine receptors. Cobenfy takes a different route.
Guidelines recommend it after two other antipsychotics have not helped. Many people wait years for it, or never get it.
Monthly research updates.